Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Matthew Wortham | |||||||
GSE216230 |
Beta cell dysfunction and dedifferentiation induced by Bone Morphogenetic Protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding [Histone ChIP-seq]
|
16 | Matthew Wortham | Jul 12, 2023 | ||||
GSE216231 |
Beta cell dysfunction and dedifferentiation induced by Bone Morphogenetic Protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding {RNA-seq]
|
6 | Matthew Wortham | Jul 12, 2023 | ||||
GSE216232 |
Beta cell dysfunction and dedifferentiation induced by Bone Morphogenetic Protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding [NeuroD1 ChIP-seq]
|
5 | Matthew Wortham | Jul 12, 2023 | ||||
GSE216233 |
Beta cell dysfunction and dedifferentiation induced by Bone Morphogenetic Protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding
|
27 | Matthew Wortham | Jul 12, 2023 | ||||
GSE134901 |
Nutrient regulation of the islet epigenome controls adaptive insulin secretion
|
131 | Matthew Wortham | Feb 24, 2023 | ||||
GSE210761 |
Systemic LSD1 inhibition prevents aberrant remodeling of metabolism in obesity
|
12 | Matthew Wortham | Oct 17, 2022 |